FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36745011000001101: Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
142081000001110 Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
142091000001112 Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Is a Tezacaftor 100mg / Ivacaftor 150mg tablets true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient Ivacaftor true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient Tezacaftor false Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Is a Symkevi true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has active ingredient Ivacaftor true Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient Tezacaftor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has AMP True Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start